TruSpine Technologies PLC Deutsche Boerse AG

Equities

9Q7

GB00BMZCKL55

Delayed Deutsche Boerse AG Other stock markets 11:34:38 06/07/2021 am IST			5-day change	1st Jan Change
0.0617 ^EUR	-24.29%		-.--%	-.--%

07/05	TruSpine Technologies says CEO Laurence Strauss resigns	AN
21/03	TruSpine Chair Miller buys GBP375,000 in shares	AN

TruSpine Technologies enters GBP50,000 loan note agreement

February 14, 2024 at 08:40 pm IST

TruSpine Technologies PLC - London Gatwick Airport-based medical device company - Enters into a GBP50,000 convertible loan note agreement with Martin Armstrong, the former non-executive chair. The CLN has been issued on an interest free basis and has a maturity date of January 31, 2025, and is unsecured.

Also says it intends to reconvene its 2022 annual general meeting "as soon as practicable."

"The company has limited working capital resources at present and continues to carefully manage its weak cash position," TruSpine says.

Current stock price: 0.7 pence

12-month change: down 61%

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Latest news about TruSpine Technologies PLC

TruSpine Technologies says CEO Laurence Strauss resigns	07/05	AN
TruSpine Chair Miller buys GBP375,000 in shares	21/03	AN
EARNINGS AND TRADING: Cykel and Mustang push back takeover deadline	15/03	AN
TruSpine Technologies raises GBP290,000 through share issue	14/03	AN
Plant Health eyes Mexico Saori launch; NARF wins deal	23/02	AN
TruSpine submits info to US FDA over Cervic-LOK applictaion	19/02	AN
TruSpine Technologies enters GBP50,000 loan note agreement	14/02	AN
TruSpine secures loan to pay fine; FDA needs Cervi-LOK clarification	05/01	AN
Loss-making TruSpine expects to raise equity or debt soon	28/12	AN
EARNINGS AND TRADING: Celebrus swings to profit; Aquila revenue flat	27/11	AN
Digital 9 dismisses call for strategic review	31/23/31	AN
TruSpine submits further documentation to FDA for Cervi-LOK	12/23/12	AN
TruSpine notes US FDA requires more info on 510k application	03/23/03	AN
EARNINGS: Eden Research loss widens on GBP5 million impairment	29/23/29	AN
TruSpine accepts Aquis findings after investigation	18/23/18	AN
TruSpine Technologies plans to appeal GBP215,000 Aquis fine	17/23/17	AN
TruSpine Technologies raises GBP50,000 through subscription	15/23/15	AN
Truspine finally files US FDA 510k submission for Cervi-LOK	25/23/25	AN
Vertu Motors "optimistic"; Atrato in Ovo Energy deal	29/23/29	AN
TruSpine Technologies takes out GBP100,000 loan from non-exec director	26/23/26	AN
TruSpine terminates services agreement, names new CEO	05/23/05	AN
Downing Renewables acquires two hydropower plants	03/23/03	AN
TruSpine Technologies inks GBP200,000 loan; CEO Ian Roberts steps down	28/23/28	AN
TruSpine says bridge loan funding yet to be received, expects to soon	20/23/20	AN
Diversified plans fundraise; Highcroft ends sale	09/23/09	AN

Chart TruSpine Technologies PLC

Duration

Period

More charts

Company Profile

Sector

More about the company